Experimental Pathology, Malmö
21 – 30 of 162
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
WNT5A as a therapeutic target in breast cancer
(
- Contribution to journal › Scientific review
-
Mark
Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes
(
- Contribution to journal › Article
- 2017
-
Mark
Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance
(
- Contribution to journal › Article
-
Mark
Optimization, validation, and identification of two reliable antibodies for immunodetection of WNT5A
(
- Contribution to journal › Article
-
Mark
Regulation of WNT5A Expression in Malignant Melanoma: Role in Tumor Progression
2017) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
(
- Contribution to journal › Article
-
Mark
Reduced production and uptake of lactate are essential for the ability of WNT5A signaling to inhibit breast cancer cell migration and invasion
(
- Contribution to journal › Article
- 2016
-
Mark
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration.
(
- Contribution to journal › Article
-
Mark
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition
(
- Contribution to journal › Article